Interpretation of guidelines for the diagnosis and treatment of primary liver cancer(2024 edition)
- VernacularTitle:《原发性肝癌诊疗指南(2024年版)》解读
- Author:
Zhao LI
1
;
Jiye ZHU
Author Information
- Keywords: Liver Neoplasms; Carcinoma,Hepatocellular; Neoadjuvant Therapy; Precision Medicine; Practice Guideline
- From: Journal of Clinical Hepatology 2024;40(7):1324-1327
- CountryChina
- Language:Chinese
- Abstract: In June 2017,National Health Commission of the People's Republic of China released Guidelines for the diagnosis and treatment of primary liver cancer(2017 edition),which provided important recommendations for the diagnosis,staging,and treatment of liver cancer.Since then,high-level evidence in line with the principles of evidence-based medicine has been continuously obtained from the research on primary liver cancer in China and globally.Therefore,National Health Commission released Guidelines for the diagnosis and treatment of primary liver cancer(2024 edition).This article gives an interpretation of the updated key points in the guidelines,in order to better guide clinical practice.
